Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.798 USD | +5.44% | -8.96% | +71.96% |
12/04 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
11/04 | Top Premarket Gainers | MT |
Sales 2024 * | 2.03M 169M | Sales 2025 * | - | Capitalization | 25.5M 2.13B |
---|---|---|---|---|---|
Net income 2024 * | -12M -1B | Net income 2025 * | - | EV / Sales 2024 * | 12.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.22
x | P/E ratio 2025 * |
-
| Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.07% |
1 day | +5.44% | ||
1 week | -8.96% | ||
Current month | -7.74% | ||
1 month | -6.46% | ||
3 months | +23.33% | ||
6 months | +101.58% | ||
Current year | +71.96% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Patel
CEO | Chief Executive Officer | 67 | 01/97/01 |
Anthony DelConte
CTO | Chief Tech/Sci/R&D Officer | 66 | - |
Krista Fogarty
AUD | Comptroller/Controller/Auditor | 56 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Dana Ono
BRD | Director/Board Member | 71 | 06/14/06 |
Mahesh Patel
CEO | Chief Executive Officer | 67 | 01/97/01 |
John W. Higuchi
BRD | Director/Board Member | 56 | 01/13/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 4.798 | +5.44% | 19,754 |
25/24/25 | 4.55 | +2.48% | 7,982 |
24/24/24 | 4.44 | -7.50% | 66,373 |
23/24/23 | 4.8 | -5.33% | 76,675 |
22/24/22 | 5.07 | -3.80% | 21,546 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.96% | 25.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- LPCN Stock